We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Collaboration Expands Point-of-Care Testing Across UK Community Pharmacies

By LabMedica International staff writers
Posted on 25 Aug 2026

HealthTab, a wholly owned subsidiary of Avricore Health, has entered a formal collaboration agreement with Abbott to supply and distribute Abbott’s point-of-care testing products in the UK through the HealthTab platform. More...

Under the agreement, HealthTab will distribute the Abbott Afinion 2 Analyzer to National Health Service (NHS)-linked pharmacies for hemoglobin A1c (HbA1c) and lipid profile testing. The collaboration also establishes a framework for expanding point-of-care testing services across community pharmacy networks.

HealthTab provides a turnkey solution for pharmacy-based testing programs that includes instruments, consumables, onboarding, training, and ongoing support. At the center of the offering is a secure cloud platform that connects point-of-care analyzers with patient results, quality control data, and pharmacist workflows, creating a unified digital infrastructure across participating locations. The platform is designed to support quality-assured testing, standardized data capture, and real-time analytics for public health reporting and performance monitoring, while reducing implementation complexity for pharmacy partners.

To support analytical performance and reliability, HealthTab partners with CEQAL Inc., a reference method laboratory and member of the U.S. Centers for Disease Control and Prevention (CDC) Cholesterol Reference Method Laboratory Network. The quality program mirrors accredited clinical laboratories through centralized lot monitoring of reagents, mandated internal quality control, and regular external quality‑assessment events. These measures help ensure results generated across participating pharmacies are accurate, traceable, and consistent with internationally recognized reference standards.

“This agreement represents our most significant milestone to date,” said Rodger Seccombe, CEO of Avricore Health. “We’ve spent fifteen years building and proving the model for pharmacy-based point-of-care testing, and we’ve learned that solving this problem takes more than great technology — it takes an industry-leading partner willing to invest the people, expertise, and resources needed to make it successful. We couldn’t have asked for a better team to be working with, and together we’re going to make a real impact on patient care.” 

Related Links
Avricore Health
Abbott


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.